Search Results - Rosenquist, Richard

TP53 mutations are infrequent in newly diagnosed chronic lymphocytic leukimia by Zainuddin, Norafiza, Murray, Fiona, Kanduri, Meena, Gunnarsson, Rebeqa, E. Smedby, Karin, Enblad, Gunilla, Jurlander, Jesper, Juliusson, Gunnar, Rosenquist, Richard

Get full text
Get full text

Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma by Zainuddin, Norafiza, Kanduri, Meena, Berglund, Mattias, Lindell, Monica, Amini, Rose-Marie, Roos, Göran, Sundström, Christer, Enblad , Gunilla, Rosenquist, Richard

Get full text
Get full text

TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype by Zainuddin, Norafiza, Berglund, Mattias, Wanders, Alkwin, Ren, Zhi-Ping, Amini, Rose-Marie, Lindell, Monica, Kanduri, Meena, Roos, Göran, Rosenquist, Richard, Enblad, Gunilla

Get full text
Get full text

Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukimia by Kaderi, Mohd Arifin, Mansouri, Mahmoud, Zainuddin, Norafiza, Cahill, Nicola, Gunnarsson, Rebeqa, Jansson, Mattias, Kimby, Eva, Aleskog, Anna, Lundin, Jeanette, Glimelius, Bengt, Melbye, Mads, Juliusson, Gunnar, Jesper Jurlander, Jesper, Rosenquist, Richard

Get full text
Get full text

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis by Benner, Axel, Mansouri, Larry, Rossi, Davide, Majid, Aneela, Willander, Kerstin, Parker, Anton, Bond, Gareth, Pavlova, Sarka, Nückel, Holger, Merkel, Olaf, Ghia, Paolo, Montserrat, Emili, Kaderi, Mohd Arifin, Rosenquist, Richard, Gaidano, Gianluca, Dye, Martin J.S., Söderkvist, Peter, Linderholm, Mats, Oscier, David, Tvaruzkova, Zuzana, Pospisilova, Sarka, Dührse, Ulrich, Greil, Richard, Döhner, Hartmut, Stilgenbauer, Stephan, Zenz, Thorsten

Get full text
Get full text
Get full text
Get full text